Baird Maintains Outperform on Alto Neuroscience, Lowers Price Target to $36
Alto Neuroscience Inc ANRO
$20.05
▼ -0.84%
($-0.17)
Open
$20.02
Prev Close
$20.22
Day Range
$19.33 – $20.34
52W Range
$2.15 – $28.44
Market Cap
$709.60M
Beta
2.25
EPS (TTM)
$-2.45
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2024-02-02 |
| Shares Out. | 35,090,000 |
| Website | altoneuroscience.com/ ↗ |
| Phone | 17732555012 |
Alto Neuroscience Inc is a publicly traded company under the ticker symbol ANRO on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-05-01)